The vaccine yields fewer antibodies against the variant discovered in South Africa, and so the company plans to test an alternate version.
View original article
Contributor: Denise Grady
The vaccine yields fewer antibodies against the variant discovered in South Africa, and so the company plans to test an alternate version.
View original article
Contributor: Denise Grady